Overall rank by patents
#29,708
of 49,997 tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 5 technology areas, recorded in grant years 2016–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G02F (Optical Devices OR Arrangements FOR THE Control OF Light BY Modification OF THE Optical Properties OF THE Media OF THE Elements Involved THEREIN; Non-linear OPTICS; Frequency-changing OF LIGHT; Optica).
The verdict
According to USPTO PatentsView, Ortus ranks #29,708 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 5 technology areas.
USPTO PatentsView assignee plate
Corpus R29708 · Foreign Corporation #29,708 · 9 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Opus Medical Therapies, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Ortus Technology · this assignee
24 score
3D Lighting… · lowest
7 score
What this shows Ortus's Innovation Score is 23.9/100 (13th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Ortus Technology Co., Ltd. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under G02F (Optical Devices OR Arrangements FOR THE Control OF Light BY Modification OF THE Optical Properties OF THE Media OF THE Elements Involved THEREIN; Non-linear OPTICS; Frequency-changing OF LIGHT; Optica). Peak complete grant year is 2018 (4 grants) versus a trough of 1 in 2016. By volume, Ortus sits between Opus Medical Therapies, LLC and Otto Bock Mobility Solutions GMBH.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Opus Medical Therapies, LLC
9 patents
Organic Construction System, S.A. DE C.V.
9 patents
Oriental Yeast Co., Ltd.
9 patents
Orkli, S.COOP.
9 patents
OSI Pharmaceuticals, LLC
9 patents
Osram Gesellschaft mit beschraenkter Haftung
9 patents
Ossio Ltd
9 patents
Otto Bock Mobility Solutions GMBH
9 patents
Ortus Technology Co., Ltd.
9 patents
What this shows Ortus holds 9 patents at rank #29,653, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #29,653 in granted patent volume.
Other assignees with the most granted patents in Ortus's primary technology class.
Ortus's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
24 13th percentile higher than 13% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 11.1% |
| 2017 | 2 | 22.2% |
| 2018 | 4 | 44.4% |
| 2019 | 2 | 22.2% |
Top 5 of 5 technology areas
Overall rank by patents
#29,708
of 49,997 tracked assignees
23.9 out of 100
What to do with this data
Ortus Technology Co., Ltd.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.